Details for Patent: RE36481
✉ Email this page to a colleague
Summary for Patent: RE36481
Title: | HMG-CoA reductase inhibitors |
Abstract: | Novel 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors are useful as antihypercholesterolemic agents and are represented by the following general structural formulae (I) and (II): ##STR1## |
Inventor(s): | Inamine; Edward S. (Rahway, NJ), Hensens; Otto D. (Red Bank, NJ), Houck; David R. (Los Alamos, NM), Lee; Ta J. (Lansdale, PA), Smith; Robert L. (Lansdale, PA), Halczenko; Wasyl (Hatfield, PA), Hartman; George D. (Lansdale, PA), Stokker; Gerald E. (Gwynedd Valley, PA) |
Assignee: | Merck & Co., Inc. (Rahway, NJ) |
Application Number: | 09/188,158 |
Patent Claim Types: see list of patent claims | Compound; Composition; Use; |
Drugs Protected by US Patent RE36481
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent RE36481
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 7455987 | ⤷ Try a Trial | |||
Canada | 1307263 | ⤷ Try a Trial | |||
Canada | 1340331 | ⤷ Try a Trial | |||
Canada | 1340452 | ⤷ Try a Trial | |||
Germany | 3770345 | ⤷ Try a Trial | |||
Germany | 3869282 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |